New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 24, 2014
15:11 EDTZMHZimmer valuation not reflecting Biomet deal potential, says Cantor
Cantor says Zimmer remains its preferred name in orthopedics despite its "disappointing" Q2 report, as the firm believes the stock's valuation doesn't properly reflects the potential from its tie-up with Biomet. Cantor thinks Zimmer management's synergy targets are possibly conservative and raised its price target on the stock to $117 from $113.
News For ZMH From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
April 14, 2015
14:48 EDTZMHZimmer, Stryker have mixed read through from J&J results, says Wells Fargo
Subscribe for More Information
April 13, 2015
17:07 EDTZMHZimmer announces extension of outside date for pending Biomet merger
Subscribe for More Information
April 9, 2015
09:25 EDTZMHBiomet results positive for Zimmer deal accretion, says Wells Fargo
Wells Fargo says the key takeaway from Bioment's Q3 results this morning was the company's "significant" margin improvement. The results give Wells more confidence that Zimmer's earnings accretion estimate for the acquisition is attainable and could mean potential upside.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use